Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Bil
1
Ubat
Tab.
Acarbose
100mg
Dos
Initially 50 mg
daily, increase to
3 times daily up
to 100 mg 3
times daily. Max
200 mg 3 times
daily
ADULT : 0.5 - 1 g
(max 2 g) with
plenty of water at
bedtime
Indikasi
Non insulin
dependent diabetes
mellitus (NIDDM)
when diet therapy is
insufficient
Non insulin
dependent diabetes
mellitus (NIDDM) in
combination with
existing
conventional oral
therapy where
glycaemic control is
inadequate
Preoperative
sedation
Chloral
Hydrate
Sodium
200g/ 5ml
Inj Dextrose
Anhydrous
50% w/v
According to the
needs of the
patient
For parenteral
replenishment of
fluid and minimal
carbohydrate
calories as required
by the clinical
condition of the
patient
Inj Diazepam
10mg/2ml
Status
epilepticus, by
slow IV: 5-10
every 10-15
Status epilepticus
Skeletal muscle
spasm
Anxiety disorders
Kontraindikasi
Patients less than 18
years, chronic intestinal
disorders associated
with distinct
disturbances of
digestion and
absorption,
Conditions which may
deteriorate as a result of
increased intestinal gas
formation, pregnancy,
lactation, severe renal
impairment
Hypersensitivity to
chloral hydrate products
Cardiac disease
Hepatic or renal
impairment
Pregnancy &breast
feeding
Porphyria
Gastritis
Patients with anuria,
diabetic coma,
hyperglycaemia,
intracranial or
intraspinal
haemorrhage, delirium
tremens in dehydrated
patients and glucosegalactose malabsorption
syndrome.
Do not administered
simultaneously with
blood through the same
infusion set because of
the possibility that
pseudoagglutination of
red cells may occur
Respiratory depression
Acute pulmonary
insufficiency
Severe hepatic
impairment
Acute narrow angle
glaucoma
Myasthenia gravis
Hypersensitivity to
diazepam products
Patients less than 6
months old
Alcohol intoxication
Central nervous system
depression
Inj. Digoxin
0.5mg/ 2ml
Inj.
Dobutamine
250mg/2ml
Inj
Dopamine
40mg/ml
Inj Labetalol
25mg/5ml
Hypotension and
heart failure
Ventricular fibrillation,
ventricular tachycardia
except in certain cases,
digitalis toxicity, beriberi
heart disease,
hypersensitivity to
digoxin, some cases of
hypersensitive carotid
sinus syndrome
Hypersensitivity to
dobutamine
Idiopathic hypertrophic
subaortic stenosis
Non-hypovolemic
hypotension
Pheochromocytoma
Tachyarrhythmias or
ventricular fibrillation
Hypertension crisis
Hypersensitivity to
labetalol products
Bradycardia
Asthma/obstructive
airway disease
Cardiogenic shock
Heart block overt
cardiac failure
10
11
chloride and
dextrose injection
or 5% dextrose IV
infusion,
Hypertension of
pregnancy; 20mg
per hour doubled
every 30 min to
max 160 mg per
hour
Inj
Local
Lignocaine
anesthesia :
100mg/5ml
ADULT Maximum:
200 mg; CHILD
Maximum: 30
mg/kg Cardiac
arrhythmias :
ADULT 50-100
mg IV.
Max: 200-300
mg/hour;
CHILD Loading
dose: 0.8-1
mg/kg IV
repeated if
necessary up to
3-5 mg/kg
followed by a
continuous
infusion of 10-50
mcg/kg/min
Hyoscine N- ADULT : 20 - 40 mg.
Butylbromid
Max : 40 mg 6 7
e 20 mg / ml
hourly
injection
CHILD : 0.5 mg / kg /
dose
Lignocaine
HCL 2%
injection
Local anesthesia by
infiltration IV
regional anesthesia
and nerve block.
Emergency
management of
ventricular
arrhythmias
particularly after
myocardial infarction
and cardiac surgery
Local inflammation
and/or sepsis,
septicaemia.
Hypovolaemia, heart
block and other
conduction disturbances
Bradycardia, cardiac
Decompensation or
hypotension.
Gastrointestinal
tract and genitorurinary tract spasm
Dyskinesia of the
biliary
Obstructive disease of
the gastrointestinal or
urinary tract
Narrow tract
Narrow-angle glaucoma
Cardiac tachyarrhytmias
Myasthenia gravis
Prostatic hypertrophy
with urinary retention
Paraben allergy
Local inflammation
and/or sepsis
Septicaemia
Hypovolaemia
Heart block and other
conduction disturbances
Local anesth
infiltration IV
regional anesthesia
and nerve block.
Emergency
management of
12
Mannitol
10%
injection
13
Metoclopro
mide HCL
10mg / 2ml
injection
14
Metronidazo
le 500mg /
100ml
injection
15
Prochlorpera
zine
mesylate
12.5 mg/ml
injection
ventricular
arrhythmias
particularly after
myocardial infarction
and cardiac surgery
Bradycardia
Cardiac decompensation
or hypotension
Cerebral oedema
Anuria
Pulmonary oedema /
congestion
Severe chronic heart
failure
Intracranial bleeding
Renal damage /
dysfunction ( after
initiation of mannitol
Concomitant theraphy
with drugs which are
likely to cause
extrapyramidal
reactions
Epileptics
Gastrointestinal
haemorrhage
Obstruction
Or perforation
Hypersensitivity to
metoclopromide
pheochromocytoma
1)Dyspepsia
Flatulence
Hiatus hernia
Peptic ulceration
Reflux oesophagitis
Gastritis duodenitis
Cholelithiasis
Nausea
Vomiting
2) promote bowel
transit during
diagnostic
procedures
Anaerobic infections
Hypersensitivity to
metronidazole
Vertigo / labyrinthine
disorder
16
17
18
dose.
Not recommended in
children
Ranitidine
1) ADULT : slow IV
50mg/ 2ml
injection of 50mg
injection
diluted to 20ml and
given over at least
2 minutes. Maybe
repeated every 6-8
hours or IV infusion
at rate of 25
mg/hour for 2 hour,
maybe repeated at
6-8 hours intervals
or IM
CHILD : 1
mg/kg/dose 6-8
hourly.
2) Initial slow
IVinjection of 50
mg, then
continuous infusion
of 125-250
mcg/kg/hour
Sodium
According to the
bicarbonate
needs of the
8.4%
patient. In severe
(1mmol/ml)
shock due to
injection
cardiac arrest :
50ml by IV
Comatose states
Cardiovascular collapse
1) Benign gastric/
duodenal ulceration
Reflux oesophagitis
Zollinger Ellison
syndrome
2) Stress ulcer
prophylaxis in postoperative and high
risk patients
Hypersensitivity to
ranitidine
For acceleration of
excretion in drug
intoxication (where
excretion of the drug
into the urine is
accelerated by
elevated urine pH)
and for acidosis
Mild to moderate
pain
Alkalosis
Hypernatraemia
Hypocalcaemia
Hypochloraemia
Severe pulmonary
oedema
Unknown abdominal
pain
Gastric and duodenal
ulcers
Haemorrhagic diathesis
Hypersensitivity to
aspirin or other NSAIDs
Children under 12 years
old
Hypersensitivity (attack
of asthma, angioedema,
urticaria or rhitinis)
Pregnancy ( third
trimester)
Patient with haemophilia
or haemorrhagicdisorder
Gout
19
Gastrointestinal
tract and genitourinary tract spasm,
dyskinesia of the
biliary system
20
Ibuprofen
ADULT : 200 - 400
200 mg
mg 3 times daily
Tablet (B)
after food,
Trade Name :
maximum. 2.4 g
Brufen
daily
CHILD : 20-30 mg/kg
body weight daily
in divided doses
Mefenamic ADULT: 250 - 500 mg
Acid 250 mg
3 times daily after
Tablet (B)
meals.
Trade Name : CHILD over 6
Ponstan
months: 6.5 - 25
mg/kg daily 3 - 4
times daily for not
longer than 7 days
except in juvenile
arthritis
Metoclopra ADULT over 20
mide HCl 10
years: 10 mg 3
mg Tablet
times daily.
(B )
Trade Name : ADULT between 12 Maxolon
20 years: 5 mg 3
Pain and
inflammation in
rheumatic disease
21
22
times daily.
CHILD under 12
years: 0.12
mg/kg/dose 6 - 12
hourly ii) Single
dose 5 - 10
minutes before
examination;
ADULT and CHILD
over 15 years: 10 -
Mild to moderate
pain
Gastrointestinal
ulceration or
inflammatory bowel
disease, renal/hepatic
impairment
i) Dyspepsia,
flatulence, hiatus
hernia, peptic
ulceration, reflux
oesophagitis,
gastritis, duodenitis,
cholelithiasis,
nausea, vomiting
Concomitant therapy
with drugs which are
likely to cause
extrapyramidal
reactions, epileptics,
gastrointestinal
haemorrhage,
obstruction
(mechanical), or
perforation,
hypersensitivity to
metoclopramide,
pheochromocytoma
23
Magnesium
Trisilicate
Tablet (C )
Heartburn,
dyspepsia
Hypersensitivity to
antacids,
hypophosphataemia
Oedema and
inflammation in
conjunction with
other physical or
chemotherapeutic
measures
i) Severe nausea
and vomiting
Prolase
2 tablet 4 times
Tablet( B)
daily
Trade Name :
Papase
25
ii)
Vertigo/labyrinthine
disorders
CNS depression or
coma, bone marrow
depression,
phaeochromocytoma,
hypersensitivity to
phenothiazines,
comatose states,
cardiovascular collapse
Interaction:
Tramadol, increased risk
of seizures. Procyclidine,
decreased
phenothiazine serum
concentrations,
decreased
phenothiazine
effectiveness, enhanced
anticholinergic effects
(ileus, hyperpyrexia,
sedation, dry mouth).
Levodopa, loss of
levodopa efficacy.
Ethanol, increased
central nervous system
depression and an
several weeks to 5
- 10mg daily. Not
recommended in
children
increased risk of
extrapyramidal
reactions
26
Mild to moderate
pain and pyrexia
Nephropathy
27
Decongestion of the
upper respiratory
tract in common
cold, hay fever,
allergic and
vasomotor rhinitis
and aerotitis
Angle-closure glaucoma,
hypersensitivity to
triprolidine products,
neonates.
Reversible airways
obstruction, acute
severe asthma
Hypersensitivity to
theophylline or
derivatives,
hypersensitivity to
ethylenediamine
2 - 4 years : 0.625
mg every 4 - 6
hours; maximum
dose 2.5 mg/day,
4 - 6 years : 0.938
mg every 4 - 6
hours; maximum
dose 3.744
mg/day,
4 months - 2 years :
0.313 mg every 46 hours; maximum
dose 1.25 mg/day.
28
mg/kg)
Acute severe asthma
by IV infusion : 500
mcg/kg/hour,
adjusted according
to plasmatheophylline
concentration.
CHILD : 6 month - 9
years : 1
mg/kg/hour, 10 16 years : 800
mcg/kg/hour
29
30
ADULT 5-10 ml by
IM.
CHILD 20-40 mg/kg
body weight as a
20% solution by
IM.
Hypomagnesaemia:
0.5-1 mmol/kg
body weight up to
160 mmol
magnesium over to
5 days.
Eclampsia: IV 4 g
over up to 20
minutes followed
by IV infusion at
rate of 1 g every
hour. Recurrent
seizures may
require an
additional IV bolus
of 2-4 g (4 g if
body weight over
70 kg)
Usual sedative range
Midazolam 5
2.5 - 7.5 mg (about
mg/ml
70 mcg/kg by IV
Injection
injection over 30
seconds).
Midazolam Premedication by IM
15mg/3ml
injection 70 - 100
Injection
mcg/kg 30 -60
Magnesium
Sulphate
50%
Injection
Treatment and
prophylaxis of
hypomagnesaemia.
Prevention and
treatment of lifethreatening seizures
in the treatment of
toxemias of
pregnancy (preeclampsia and
eclampsia
Pre-operative
sedation, induction
of general
anaesthesia,
premedication and
sedation in ICU and
sedation for minor
procedures
31
Morphine
Sulphate 10
mg/ml
Injection
32
Metformin
HCl 500 mg
Tablet
33
minutes before
surgery;
ELDERLY: 1 - 1.5
mg/kg. Induction:
Induction by slow
IV infusion 200 300 mcg/kg
(ELDERLY 100 200 mcg/kg. CHILD
over 7 years 150 200 mcg/kg);
Max: 0.35mg/kg.
Sedation in ICU 0.03
- 0.2 mg/kg/hour
ADULT: 10 - 20
mg/kg or more SC
or IM every 4 hours
in terminal pain.
CHILD: Up to 1
month: 0.15 mg/kg
body weight; 1 - 12
months: 0.2 mg/kg
body weight; 1 - 5
years: 2.5 - 5 mg ;
6 - 12 years: 5 - 10
mg
500 mg 3 times
daily or 850 mg
twice daily with
food, maximum: 3
g daily in 3 divided
doses
Prophylaxis fo DVT
Enoxaparin
especially in
Sodium 40
surgical patients:
mg Injectioni. moderate risk, 20
mg SC
A*
approximately 2
hours before
surgery then 20
Enoxaparin
mg every 24 hours
Sodium 60
for minimum 7 - 10
mg Injection
days,
ii. high risk (eg
orthopaedic
surgery, medical
For moderate to
severe pain
especially that
associated with
neoplastic disease
Diabetes mellitus
Diabetic pre-coma,
ketoacidosis, renal
impairment, chronic
liver disease, cardiac
failure, hypoxaemia,
history of lactic acidosis,
acute alcohol
intoxication, hypoxia
Active major bleeding,
hypersensitivity to
enoxaparin, heparin,
thrombocytopenia due
to enoxaparin, acute GI
ulcer
i) Prevention of Deep
Vein
Thrombosis(DVT)
especially in
perioperative and
high risk surgical
cases ii) Treatment
of DVT iii) Unstable
angina and non Q
wave Myocardial
Infarction
34
Fondaparinu
x Sodium 2.5
mg/0.5 ml
Injection
patients, 40mg
every 24 hours for
at least 6 days
until patient
ambulant, max 14
days.
Treatment of DVT or
pulmonary
embolism, 1.5
mg/kg every 24
hours, usually for 5
days and until
adequate oral
anticoagulation
established.
Unstable angina and
non-ST-segmentelevation
myocardial
infarction 1 mg/kg
every 12 hours,
usually for 2 - 8
days
i)2.5 mg once daily
given by SC,
administered 6 hr
following surgical
closure provided
homeostasis has
been
established.Usual
duration of therapy
is 5 to 9 days; for
hip fracture
patients, an
extended course of
up to 24 days is
recommended.
ii) ADULT more than
18 years: 2.5 mg
once daily given by
SC, initiated as
soon as possible
after diagnosis and
continued for up to
8 days or until
hospital discharge.
i) Prevention of
venous
thromboembolic
events (VTE) in
orthopedic surgery
(e.g. hip fracture,
major knee or hip
replacement
surgery), abdominal
surgery in patients
at risk of
thromboembolic
complication. ii)
Treatment of
unstable angina or
non-ST segment
elevation myocardial
infarction
[UA/NSTEMI] in
patients for whom
urgent invasive
management (PCI) is
not indicated. iii)
Treatment of ST
If patient needs to
undergo PCI,
unfractionated
heparin to be
admin as per local
practice protocol,
taking into account
the patient's
bleeding risk and
time of last dose of
fondaparinux.
Fondaparinux may
be restarted no
earlier than 2 hr
after sheath
removal.
iii) ADULT more than
18 years: 2.5 mg
once daily; first
dose to be given IV
(directly through
an existing IV line
or as infusion in 25
or 50 ml of 0.9%
saline over 1-2
min), subsequent
doses to be given
SC. Treatment to
be initiated as
soon as diagnosis
is made and
continued up to a
max of 8 days or
until hospital
discharge,
whichever comes
earlier. If patient
needs to undergo
non-primary PCI,
unfractionated
heparin to be
admin as per local
practice protocol,
taking into account
the patient's
bleeding risk and
time of last dose of
segment elevation
myocardial infarction
(STEMI) in patients
managed with
thrombolytics or are
not receiving other
forms of reperfusion
therapy
35
36
37
38
fondaparinux.
Fondaparinux may
be restarted no
earlier than 3 hr
after sheath
removal
Glyceryl
Initial 5 mcg/min
Trinitrate 50
delivered via
mg/10 ml
infusion pump.
Injection
Subsequent
titration must be
adjusted to clinical
*Glyceryl
situation with dose
Trinitrate 25
increment
mg/5 ml
becoming more
Injection
cautious as partial
response is seen.
*Prophylaxis and
treatment of angina,
left ventricular
failure. Not for direct
IV injection.
*For IV :Constrictive
pericarditis, pericardial
tamponade, restrictive
cardiomyopathy,
symptomatic
hypotension,
hypersensitivity to
organic nitrates
Hypertension
Hypersensitivity to
nifedipine. Symptomatic
hypotension.
Persistent dermatologic
reactions.
Chronic heart failure.
Angioedema induced by
other angiotensin
converting enzyme
(ACE) inhibitors.
Hypersensitivity to this
or any other angiotensin
converting enzyme
inhibitor. Pregnancy
(second and third
trimesters particularly).
Hypertension
Congestive heart
failure
Stable coronary
artery disease
single 4 mg once
BP acceptability
has been
demonstrated. 4
mg once daily for 2
weeks, may be
increased to 8 mg
once daily.
ELDERLY: 2 mg once
daily for 1 week,
then 4 mg once
daily for the
following week,
may be increased
up to 8 mg once
daily
ADULT: 2 - 3 tablets
daily.
Severe deficiency: 9
- 12 tablets daily or
according to the
needs of the
patient
39
Potassium
Chloride
(Slow K)
600mg Tab
40
41
Hypertension
i) Replacement
therapy for primary
and secondary
adrenocortical
insufficiency
ii) Adrenogenital
syndrome
iii) Other therapy
Hypersensitivity and
systemic fungal
infection.
42
Ranitidine
(Zantac)
150mg Tab
43
Theophylline
SR (Nuelin
SR) 250mg
Long Acting
Tab
44
Heparinised
Saline
Injection
every 6 - 8 hours
or as a single daily
150 mg twice daily
(at morning and
night) or 300 mg
on night for 4-8
weeks.
Maintenance: 150300 mg on night
150 mg twice daily
or 300 mg on night
for 8-12 weeks
150 mg daily or
twice daily
iv) 150 mg and may
be increased as
necessary to 6
g/day
ADULT: 250 mg 2
times daily.
CHILD under 12
years : Up to 10
mg/kg body weight
2 times daily
By IV injection,
loading dose of
5000 units (10,000
units in severe
pulmonary
embolism)
followed by
continuous infusion
of 15-25
units/kg/hr.
By SC injection (for
DVT) of 15,000
units every 12
hours (laboratory
monitoring on daily
basis essential to
adjust dose).
Small adult or child,
lower loading dose
then, 15-25
units/kg/hr by IV
infusion, or 250
units/kg every 12
Hypersensitivity to
ranitidine
Reversible airways
obstruction and
acute severe asthma
Hypersensitivity to
theophylline
i) Prophylaxis and
treatment of venous
thrombosis and
pulmonary
embolism. ii)
Treatment of
myocardial infarction
and arterial
embolism. iii)
Prevention of
clotting in arterial
and heart surgery
and for prevention of
cerebral thrombosis.
Hypersensitivity, in
patients who are
actively bleeding, or
have blood dyscrasias,
in patients with
haemophilia or other
blood disorders, and in
cases where sufficient
blood coagulation tests
are not available
hours by SC
injection.
As for unstable
angina and acute
peripheral arterial
occlusion.
Prophylaxis in
general surgery, by
SC injection, 5000
units 2 hour before
surgery, then
every 8-12 hours
for 7 days or until
patient is
ambulant, during
pregnancy (with
monitoring), 500010000 units every
12 hours. An
adjusted dose
regimen may be
used for major
orthopaedic
surgery or low
molecular weight
heparin may be
selected
According to the
needs of the
patient
45
Water for
Injection
46
Insulin
Dose to be
Recombinan
individualised.
t Synthetic The average daily
Human,
insulin requirement
intermediate
is between 0.5-1.0
-acting 100
units/kg body
IU/ml Penfill
weight.
and Refill B
(Insulatard)
As a diluent and
vehicle for the
administration of
medications
Insulin dependent
diabetes mellitus,
non insulin
dependent diabetes
unresponsive to
treatment to diet or
oral
hypoglycaemics,
hyperkalaemia to
assure proper
utilisation of glucose
and reduce
glucosuria in non
diabetic patients
receiving parenteral
nutrition
Not known
Hypoglyacemia.
Insulinoma.
47
48
Benzylpenici Peads: 50
llin 5 mega
100mg/kg daily in
units (3g) Inj
2-4 divided doses
(narrowIV
spectrum
Dewasa: 600
anti-infective
1200mg IM qid, @
7.2g daily in 6
divided doses by
slow IV infusion
49
Calcium
Gluconate
10% Inj
(Calcium)
50
Peads: 50mg/kg
Dewasa: 1g (2.2
mmol), diikuti
continuous infusion
4g (8.8 mmol)/day
IV / intracardiac inj:
10 ml
Jangkitan
susceptible
organism pada
saluran respiratori,
kulit, tisu lembut,
GUT
Septicaemia,
peritonitis,
osteomyelitis, postoperative infection
Infective
endocarditis
Jangkitan oleh
susceptible
organism
(Neisseria gonorrhoe
a, Corynebacterium
diphtheriae, Bacillus
anthracis, Clostridia,
Actinomyces bovis,S
treptobacillus monili
formis, Listeria mon
ocytogenes,and Lept
ospira; Treponema p
allidum)
Acute
hypocalcaemia
Hypocalcaemic
tetany
Cardiac resuscitation
Magnesium
overdose
Black widow spider
bites
Hyperkalaemia
Osteoporosis
Post-menopausal
Jangkitan oleh
susceptible
organism (otitis
media, PID, UTI,
meningitis, Lower
Respiratory Tract
infection)
Surgical prophylaxis
Hypersensitivity
terhadap penicillin
Sejarah penicillinassociated cholestatic
jaundice
Sejarah disfungsi hepar
Sejarah anaphylaxis,
hypersensitivity
terhadap penicillin
Hypercalcaemia
Hypercalciurea
Kegagalan ginjal teruk
Pengambilan digitalis
Hypersensitivity
terhadap cephalosporin
Neonates yang
menjalani rawatan
cecair IV yang
mengandungi calcium
51
52
intervals)
Surgical prophylaxis:
1 g IV 0.5 2 hr
prior procedure
Cefuroxime Peads: 30 100
sodium
mg/kg/day in 3-4
750mg Inj
divided doses
(broad Dewasa: 750mg 6-8
spectrum
hr IM atau IV.
anti-infective)
(Jangkitan teruk:
1.5g bid/qid daily
IV)
Surgical prophylaxis:
1.5g IV
Cloxacillin
Peads < 20kg: 20
sodium
50mg/kg/day in
500mg Inj
equally divided
(narrowdoses q 6 hr
spectrum
Dewasa: 250 anti-infective)
500mg q 6 hr
53
Dextrose
50% Inj
(carbohydrate
)
Bergantung kepada
keperluan pesakit
54
Diclofenac
sodium
75mg/3ml Inj
(NSAID)
Jangkitan oleh
susceptible
organism (Lyme
disease, gonorrhea,
meningitis, UTI,
septicaemia)
Surgical prophylaxis
Hypersensitivity
terhadap cephalosporin
Jangkitan oleh
susceptible bacteria,
terutama
penicillinaseproducing
staphylococci
Pneumonia
Osteomyelitis
UTI
Memulihkan
keperluan cecair dan
kalori badan pesakit
yang:
o Tidak sedar
o Tidak
mampu/boleh
mengambil
cecair/pepejal
melalui oral
Hypersensitivity
terhadap penicillin /
produk cloxacillin
Anuria
Diabetic coma
Hyperglycaemia
Intracranial/intraspinal
haemorrhage
Dehydrated patients
dengan delirium
tremens
Glucose-galactose
malabsorption syndrome
Simultaneously with
blood via same infusion
set (may cause
pseudoagglutination of
red blood cells)
Hypersensitivity
terhadap diclofenac
dan//atau bahan
ramuannya
Pengambilan
aspirin/NSAIDs lain
Asthma
Rhinitis
Porphyria
Pregnancy (trimester ke-
55
Frusemide
Peads: 0.5
20mg/2ml inj
1.5mg/kg (max:
(Diuretic)
20mg daily)
Dewasa: (Initial) 20
40mg IM / slow IV
(kadar tak melebihi
4mg/min)
Pulmonary oedema
56
Merawat keradangan
(inflamasi) seperti
dalam kes:
o Allergic reaction
o Arthritis
o Penyakit
autoimmune
(penyakit darah,
kanser)
o Asthma /
masalah
respiratori
Penggantian steroid
dalam kes adrenal
insufficiency
57
Insulin
Dose to be
Recombinan
individualised. The
t Neutral
average daily
Human
insulin requirement
short-acting
is between 0.5-1.0
100 IU/ml
units/kg body
Injection in
10ml vial B
weight
Trade Name :
Actrapid/Hum
ulin
58
Insulin dependent
diabetes mellitus,
non insulin
dependent diabetes
unresponsive to
treatment to diet or
oral
hypoglycaemics.
hyperkalaemia to
assure proper
utilisation of glucose
and reduce
glucosuria in non
diabetic patients
receiving parenteral
nutrition
Only for treatment
of : i) Patients with
ischaemic heart
disease who develop
extrasystole with
salbutamol or
terbutaline ii)
3)
Hypersensitivity
terhadap furosemide
Anuria
Hepatic coma & precoma
Hypokalaemia /
hyponatraemia teruk
hypovolaemia
Hypersensitivity
Jangkitan fungus
sistemik
Hypoglyacemia,
insulinoma
Hypersensitivity to
ipratropium products,
atropine, soya lecithin or
related food products
Bromide
0.025%
Inhalation
Solution
(250
mcg/ml) B
Trade Name :
Atrovent
daily
59
60
Cough
Hypersensitivity to
diphenhydramine or
other antihistamines of
similar chemical
structure, lactation,
newborns or infants.
61
Potassium
ADULT: 10 ml 3
Citrate 3
times daily well
g/10 ml and
diluted with water.
Citric Acid
CHILD up to 1 year:
Mixture
2.5 ml 3 times
daily; 1 - 5 years: 5
ml 3 times daily; 6
- 12 years: 10 ml 3
times daily. To be
taken well diluted
with water
62
Magnesium
Trisilicate
Heartburn,
dyspepsia
Hypersensitivity to any
of their component
Mixture
63
64
65
antacids,
hypophosphataemia
Oral
ADULT: 200 - 400 ml
Rehydration
( 1 - 2 sachets ) for
Salt
every loose
motion.
CHILD: 200 ml (1
sachet) for every
loose motion. In
severe dehydration
100 ml/kg for 3 - 4
hours.
INFANT: 1 - 1.5 times
their usual feed
volume (50 ml per
stool for small
infant)
Potassium
By slow IV infusion
Chloride 1
depending on the
g/10 ml
deficit or the daily
Injection
maintenance
requirements. 1 g
diluted in 500 ml
normal saline or
glucose and given
slowly over 2 - 3
hours
Replacement of fluid
and electrolytes loss
in diarrhoea
Lactulose
ADULT 15 ml twice
3.35 g/5 ml
daily adjusted to
Liquid B
patient's need.
Trade Name :
CHILD 0.5
Duphalac
ml/kg/dose once or
twice daily
30-50 ml 3-4 times
daily, dose
adjusted to
produce 2-3 soft
stools daily.
CHILD 1 ml/kg/dose
3-4 times daily
i) Constipation
ii) Hepatic
encephalopathy
Galactosaemia,
intestinal obstruction
Ubat
Adrenaline 1mg/ml Inj.
Aminophylline 250mg/
10ml Inj.
Atropine Sulphate 1mg/ml
Inj.
Calcium Gluconate 1g/10
ml Inj.
Chlorpheniramine 10mg/ml
Inj.
Dexamethasone8mg/2ml
Inj.
Dextrose 50% w/v Inj
Digoxin 0.5 mg/2ml I
Dobutamine 250mg/20ml
Inj.
Dopamine 40mg/ml Inj.
Flumazenil 0.5mg/5ml Inj.
Frusemide 20mg/2ml Inj.
Glyceryl Trinitrate 0.5mg
Tab.
Glyceryl Trinitrate 50mg/
10ml Inj.
Hydrocortisone 100mg Inj.
Labetalol 25mg/5ml Inj.
Lignocaine HCl 100mg/5ml
Inj.
Naloxone HCl 0.4mg/ml
(Adult) Inj.
Noradrenaline 4mg/4ml Inj.
Phenytoin Sodium
250mg/5ml Inj.
Promethazine 50mg/2ml
Inj.
Sodium Bicarbonate 8.4%
Inj.
Terbutaline Sulphate
2.5mg/ml Inj.
Verapamil 5mg/2ml Inj.
4
2
5